StonvexLoading…
StonvexStonvexStonvexCore line items from RYM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $17.28M | $18.00K | $15.14M | $58.26M |
Operating Income | $-32.34M | $-5.07M | $-13.02M | $-193.33M |
Net Income | $-33.26M | $-41.75M | $-18.65M | $-188.17M |
EPS (Diluted) | $-16.68 | $-40.92 | $-187.64 | $-902.19 |
Total Assets | $106.68M | $54.02M | $45.27M | $69.69M |
Total Liabilities | $93.66M | $25.93M | $59.98M | $78.73M |
Cash & Equivalents | $32.20M | $31.17M | $434.00K | $10.46M |
Free Cash Flow OCF − CapEx | Not available | $-11.59M | $-31.03M | $-80.16M |
Shares Outstanding | 2.15M | 1.95M | 113.42K | 1.04M |